Zacks Investment Research cut shares of Aemetis Inc. (NASDAQ:AMTX) from a hold rating to a sell rating in a research note published on Wednesday morning.
According to Zacks, “Aemetis, Inc. is an advanced fuels and renewable chemicals company. It produces renewable chemicals and fuels using patented microbes and processes. Aemetis owns and operates an ethanol animal feed plant in California to produce D5 Advanced Biofuels using the sorghum/biogas/CHP pathway. The Company also built, owns, and operates a renewable chemicals and advanced fuels production facility on the East Coast of India producing high quality, distilled biodiesel and refined glycerin for customers in Europe and Asia. Aemetis, Inc. is headquartered in Cupertino, California. “
Separately, FBR & Co reiterated a hold rating and issued a $1.75 price target on shares of Aemetis in a research report on Thursday, September 8th.
Aemetis (NASDAQ:AMTX) opened at 1.33 on Wednesday. The firm has a 50-day moving average price of $1.35 and a 200-day moving average price of $2.02. Aemetis has a 12 month low of $1.01 and a 12 month high of $3.05. The company’s market capitalization is $26.41 million.
Aemetis (NASDAQ:AMTX) last released its quarterly earnings results on Thursday, August 11th. The company reported ($0.25) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.26) by $0.01. The business earned $33.10 million during the quarter, compared to analyst estimates of $38.10 million. On average, equities analysts anticipate that Aemetis will post ($1.04) earnings per share for the current fiscal year.
Aemetis, Inc is an international renewable fuels and biochemicals company. The Company is focused on the production of fuels and chemicals through the acquisition, development and commercialization of technologies that replace traditional petroleum-based products by conversion of first-generation ethanol and biodiesel plants into biorefineries.